Health Status Function After Treatment with Thermal Balloon Endometrial Ablation and Levonorgestrel Intrauterine System for Idiopathic Menorrhagia: a Randomized Study
Overview
Authors
Affiliations
Aim: To compare patients' health status function after treatment with thermal balloon endometrial ablation (TBEA) and levonorgestrel intrauterine system (LNG-IUS) for idiopathic menorrhagia.
Methods: Forty-four patients were recruited into a randomized trial comparing their health status after treatment with TBEA or LNG-IUS for idiopathic menorrhagia.
Results: At 1 year follow-up, the mean haemoglobin was significantly higher in women treated with TBEA (12.6 g/dl vs. 10.3 g/dl, p = 0.018). Iron deficiency occurred in 13.3% from the TBEA arm and in 50% from the LNG-IUS arm (p = 0.026). The women's mean Short Form 36 Questionnaire general health perception scores (54.9 vs. 40.5, p = 0.024) and mental health scores (49.5 vs. 38.3, p = 0.021) in TBEA arm were significantly higher than in the LNG-IUS arm. The mental health domain score was also significantly lower in the LNG-IUS arm (46.1 vs. 38.3, p = 0.041).
Conclusion: TBEA appears to offer better health status function at 1 year follow-up and to be more acceptable to our Chinese population in the treatment of idiopathic menorrhagia following failed medical treatment.
First and second-generation endometrial ablation devices: A network meta-analysis.
Marchand G, Masoud A, Grover S, King A, Brazil G, Ulibarri H BMJ Open. 2024; 14(5):e065966.
PMID: 38806429 PMC: 11138282. DOI: 10.1136/bmjopen-2022-065966.
Cooper N, Papadantonaki R, Yorke S, Khan K Facts Views Vis Obgyn. 2022; 14(3):205-218.
PMID: 36206795 PMC: 10350948. DOI: 10.52054/FVVO.14.3.030.
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.
Bofill Rodriguez M, Dias S, Jordan V, Lethaby A, Lensen S, Wise M Cochrane Database Syst Rev. 2022; 5:CD013180.
PMID: 35638592 PMC: 9153244. DOI: 10.1002/14651858.CD013180.pub2.
Mansour D, Hofmann A, Gemzell-Danielsson K Adv Ther. 2020; 38(1):201-225.
PMID: 33247314 PMC: 7695235. DOI: 10.1007/s12325-020-01564-y.
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Bofill Rodriguez M, Lethaby A, Jordan V Cochrane Database Syst Rev. 2020; 6:CD002126.
PMID: 32529637 PMC: 7388184. DOI: 10.1002/14651858.CD002126.pub4.